NF
AEMD icon

NTB Financial’s Aethlon Medical AEMD Stock Holding History

NTB Financial’s Portfolio AEMD Stock Details AEMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		$24K Hold
5
– – 0.02% 142
2022
Q1 		$28K Buy
5
+1
+25% +$5.97K 0.02% 152
2021
Q4 		$32K Buy
+4
New +$45.5K 0.02% 147

Other funds holding AEMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
N
Natixis Paris, France $24.8B AUM 35.22% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
CFN
Cordasco Financial Network Naples, Florida $138M AUM 10.5% 1-Year Est. Return
TSS
Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return

NTB Financial's AEMD Position: Q2 2022 in Review

NTB Financial held its Aethlon Medical (AEMD) position steady in Q2 2022 at 5 shares worth $24K. The position accounts for 0.02% of the portfolio, ranked #142.

NTB Financial first reported a position in AEMD in Q4 2021 and has held it in 3 quarters since. The position peaked at $32K in Q4 2021. 20 funds tracked by Wall St. Rank hold AEMD as of Q2 2022.

  • NTB Financial held 5 shares of Aethlon Medical worth $24K as of Q2 2022.
  • NTB Financial left its Aethlon Medical share count unchanged in Q2 2022.
  • Aethlon Medical made up 0.02% of NTB Financial's portfolio in Q2 2022, its #142 holding.
  • NTB Financial first reported a position in Aethlon Medical in Q4 2021 and has held it in 3 quarters since.
  • NTB Financial's Aethlon Medical position peaked at $32K in Q4 2021.
  • 20 funds tracked by Wall St. Rank held Aethlon Medical as of Q2 2022.

Based on NTB Financial's 13F filing for Q2 2022, filed 9 Aug 2022.